Scott Shuda - 07 Jul 2025 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)

Role
Director
Signature
/s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
Issuer symbol
INFU
Transactions as of
07 Jul 2025
Transactions value $
-$55,622
Form type
4
Filing time
22 Aug 2025, 17:33:54 UTC
Previous filing
24 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shuda Scott Director C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS /s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda 22 Aug 2025 0001486636

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INFU Common Stock Other $0 -2.24K -2.2% $0.00 99.8K 07 Jul 2025 Direct F2
transaction INFU Common Stock Sale -$55.6K -5.75K -5.77% $9.67 94K 22 Aug 2025 Direct F2
holding INFU Common Stock 298K 07 Jul 2025 Footnote 1 F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II ("BlueLine"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine.
F2 The transactions relate to shares originally held by a partnership, Meridian TSV II, LP, that was dissolved with the result of Mr. Shuda taking custody of the shares. In July 2025, Mr. Shuda distributed shares to one former member of the partnership and in August 2025, Mr. Shuda sold shares for the benefit of the other partners. No shares remain relating to the partnership and no other shares are planned to be sold. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $9.57 to $9.83. The reporting person undertakes to provide the company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.